TransCure BioServices Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 74

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 6

TransCure BioServices General Information

Description

Developer of humanized mouse models intended to accelerate the development and commercialization of new drugs and therapies for cancer. Developer of humanized mouse models intended to accelerate the development and commercialization of new drugs and therapies for cancer. The company allows researchers to rapidly and efficiently generate and characterize humanized mouse models, which are more predictive of human drug response than traditional animal models, enabling pharmaceutical companies and other life science organizations to bring new therapies to market faster and more cost-effectively.

Contact Information

Formerly Known As
TCS
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • 260 avenue Marie Curie
  • 74160 Archamps
  • France
+33 04
Primary Industry
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 260 avenue Marie Curie
  • 74160 Archamps
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TransCure BioServices Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TransCure BioServices‘s full profile, request access.

Request a free trial

TransCure BioServices Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of humanized mouse models intended to accelerate the development and commercialization of new drugs and therap
Biotechnology
Archamps, France
74 As of 2026

Kobe, Japan
 

Dijon, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TransCure BioServices Competitors (8)

One of TransCure BioServices’s 8 competitors is VC Cell Therapy, a Venture Capital-Backed company based in Kobe, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
VC Cell Therapy Venture Capital-Backed Kobe, Japan
Oncodesign Services Private Equity-Backed Dijon, France
Yecuris Private Equity-Backed Tualatin, OR
GemPharmatech Formerly VC-backed Nanjing, China
AAVantgarde Bio Venture Capital-Backed Rome, Italy
You’re viewing 5 of 8 competitors. Get the full list »

TransCure BioServices Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TransCure BioServices Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore TransCure BioServices‘s full profile, request access.

Request a free trial

TransCure BioServices FAQs

  • When was TransCure BioServices founded?

    TransCure BioServices was founded in 2012.

  • Where is TransCure BioServices headquartered?

    TransCure BioServices is headquartered in Archamps, France.

  • What is the size of TransCure BioServices?

    TransCure BioServices has 74 total employees.

  • What industry is TransCure BioServices in?

    TransCure BioServices’s primary industry is Biotechnology.

  • Is TransCure BioServices a private or public company?

    TransCure BioServices is a Private company.

  • What is TransCure BioServices’s current revenue?

    The current revenue for TransCure BioServices is .

  • How much funding has TransCure BioServices raised over time?

    TransCure BioServices has raised $4.3M.

  • Who are TransCure BioServices’s investors?

    Ad-hoc Invest, Alpes Leman Angels, Angelor, Cathay Capital, and Financiere Arbevel are 5 of 8 investors who have invested in TransCure BioServices.

  • Who are TransCure BioServices’s competitors?

    VC Cell Therapy, Oncodesign Services, Yecuris, GemPharmatech, and AAVantgarde Bio are some of the 8 competitors of TransCure BioServices.

  • When was TransCure BioServices acquired?

    TransCure BioServices was acquired on 20-Jan-2026.

  • Who acquired TransCure BioServices?

    TransCure BioServices was acquired by Taconic Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process